AGAPE ATP CORPORATION (ATPC) Gross Margin
- Gross margin · 12 months: Value 59.22%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 59.22% | Gross profit / revenue. Period ending 2026-06-30. $779.18K ÷ $1.32M × 100 ≈ 59.22% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 779.18K USD | Gross Profit |
| Revenue | 1.32M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $779.18K | $1.32M | (m) | 59.22% |
| 2026-03-31 | $841.39K | $1.51M | (m) | 55.76% |
| 2025-12-31 | $838.27K | $1.52M | (m) | 55.00% |
| 2025-09-30 | $782.31K | $1.48M | (m) | 52.68% |
| 2025-06-30 | $727.39K | $1.45M | (m) | 50.32% |
| 2025-03-31 | $712.01K | $1.29M | (m) | 55.06% |
| 2024-12-31 | $759.15K | $1.32M | (m) | 57.39% |
| 2024-09-30 | $834.60K | $1.35M | (m) | 61.64% |
| 2024-06-30 | $885.14K | $1.38M | (m) | 64.23% |
| 2024-03-31 | $887.58K | $1.37M | (m) | 64.84% |
| 2023-12-31 | $936.57K | $1.43M | (m) | 65.44% |
| 2023-09-30 | $744.67K | $1.43M | $682.36K | 52.18% |
| 2023-06-30 | $1.02M | $1.74M | $719.52K | 58.54% |
| 2023-03-31 | $1.11M | $1.83M | $720.97K | 60.57% |
| 2022-12-31 | $1.19M | $1.86M | $666.04K | 64.13% |
| 2022-09-30 | $1.19M | $1.68M | $488.01K | 70.95% |
| 2022-06-30 | $850.13K | $1.22M | $366.93K | 69.85% |
| 2022-03-31 | $830.97K | $1.12M | $293.17K | 73.92% |
| 2021-12-31 | $719.63K | $1.02M | $297.33K | 70.76% |
| 2021-09-30 | $1.06M | $1.32M | $267.29K | 80.06% |
| 2021-06-30 | $2.12M | $2.53M | $417.51K | 83.67% |
| 2021-03-31 | $2.90M | $3.74M | $853.45K | 77.64% |
| 2020-12-31 | $2.68M | $3.43M | $775.86K | 77.94% |
| 2020-09-30 | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) |
| 2019-12-31 | $89.30K | $1.29M | $1.20M | 6.92% |
| 2019-09-30 | $98.76K | $1.37M | $1.27M | 7.22% |
| 2019-06-30 | $109.35K | $1.55M | $1.44M | 7.07% |
| 2019-03-31 | $109.99K | $1.15M | $1.04M | 9.57% |
| 2018-12-31 | $65.70K | $682.79K | $617.09K | 9.62% |
| 2018-09-30 | $36.65K | $412.25K | $375.59K | 8.89% |
| 2018-06-30 | $45.60K | $487.00K | $441.41K | 9.36% |
| 2018-03-31 | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |